/PRNewswire/ Accuredit Therapeutics (Suzhou) Co., Ltd. (hereinafter referred to as Accuredit), an emerging company based on new generations of safe and.
Accuredit Therapeutics Appointed Dr. Fuxin Shi as Head of New Drug Discovery & Preclinical Research and General Manager of the US Subsidiary - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ Accuredit Therapeutics (Suzhou) Co. Ltd (hereinafter referred to as Accuredit) announced today that the accomplished scientist Dr. Fuxin Shi.